Clinical Trials Logo

Stuttering, Adult clinical trials

View clinical trials related to Stuttering, Adult.

Filter by:
  • None
  • Page 1

NCT ID: NCT06278233 Recruiting - Stuttering, Adult Clinical Trials

Bihemispheric Transcranial Direct Current Stimulation* on Speech Fluency

TDCS
Start date: February 2024
Phase: N/A
Study type: Interventional

It will be determined whether bihemispheric stimulation (anodal to the left IFG and cathodal to the right IFG) is used with fluency-facilitating conditions for 5 consecutive days in individuals with stuttering and whether there is a difference in terms of the effects seen in speech fluency compared to the sham condition.

NCT ID: NCT06059729 Completed - Stuttering, Adult Clinical Trials

Effects of Al-Lisaan Urdu Digital Software for Self-Assessment and Treatment of Adult Stutters

Al-Lisaan
Start date: September 11, 2023
Phase: N/A
Study type: Interventional

The study plans to find the efficacy of a digital application/software, Al-lisan that adult stutters can be used for assessment and management of their stuttering. The Software has been developed with the help of a software engineer. After the current trends employed by Speech language pathologists explored through qualitative study design, the manual which is under development process through a focused group in which assessment and treatment options of the software were finalized. The next step will include the reliability and validity of the software for assessment and management of adult stutters followed by finding the efficacy of the software. As this Application will be in Urdu language it will assist less literate and those living in peripheries to assess or provide self-treatment options to the persons who stutter. It will allow adults for self-assessment and treatment options in Urdu language.

NCT ID: NCT06011837 Recruiting - Stuttering, Adult Clinical Trials

Effects of Altered Auditory Feedback on Speech Fluency

Start date: May 26, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to use altered auditory vocal feedback to increase fluency in people who stutter and to examine changes in this effect over the course of a one month period occurring outside the laboratory setting.

NCT ID: NCT05908123 Recruiting - Stuttering Clinical Trials

Exploring the Nature, Assessment and Treatment of Stuttering

Start date: May 22, 2015
Phase: N/A
Study type: Interventional

The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.

NCT ID: NCT05574803 Completed - Stuttering, Adult Clinical Trials

High-definition tDCS Treatment for Cantonese-speaking Adults Who Stutter

Start date: July 27, 2021
Phase: N/A
Study type: Interventional

The proposed study aims to investigate the effect of combined transcranial direct current stimulation (tDCS) and behavioural speech training in improving speech fluency in Cantonese-speaking adults who stutter (AWS), and to examine its maintenance over a 6-week period.

NCT ID: NCT05472181 Recruiting - Stuttering, Adult Clinical Trials

The Effects of Brain Stimulation on Speech Fluency in Adults Who Stutter

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The project is leading to investigate the effects of neuromodulation techniques on speech fluency among adults who stutter (AWS). While stuttering is responsive to a variety of treatments in childhood, this is not the case for AWS. Behavioural treatments to reduce stuttering for adults typically consist of speech restructuring methods, which involves the person using one of the altered speech patterns known to increase fluency, such as chorus reading, speaking in rhythm, and prolonging (smoothing/stretching out) speech sounds. Research has shown that behavioural interventions such as these change brain activation patterns in the regions associated with stuttering. Unfortunately, around 70% of AWS who receive these speech restructuring treatments do not maintain the benefits in the longer term and frequently re-present to speech clinics. The aim of this proposed research is to explore whether the brain stimulation using repetitive transcranial magnetic stimulation (rTMS) can consistently enhance effects of behavioural stuttering therapy by examining their responsiveness to the treatment across different outcome measures including a) immediate effect on different speaking contexts, and b) the maintenance of effects over one week after therapy.

NCT ID: NCT05339906 Recruiting - Stuttering, Adult Clinical Trials

Study of the Effect of the Auditory Stimulation on Stuttering Symptoms in Patients With a Deficit of Spectral Power in the EEG Beta Frequency Band

ZOV
Start date: May 25, 2021
Phase: N/A
Study type: Interventional

In this study, the investigators will research the efficacy of a novel auditory neuro modulating technology that leverages euphonic music tracks with broad-spectrum binaural beats to induce selective EEG spectral power changes.

NCT ID: NCT04929184 Recruiting - Stuttering Clinical Trials

Speech Processing in Stuttering

Start date: April 4, 2022
Phase: N/A
Study type: Interventional

This research is being done to better understand stuttering, specifically how people who stutter may process and/or produce speech. Eligible participants enrolled will complete a variety of computer and speech-based tasks on up to 2 visits.

NCT ID: NCT02909088 Recruiting - Speech Disorders Clinical Trials

Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).

Start date: September 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the efficacy and tolerability of ecopipam in reducing stuttering symptoms. It is hypothesized that ecopipam effectively reduces stuttering symptoms as measured on the SSI-IV total score, the CGI, SSS and OASES.